Marta Vachová

2.7k total citations
21 papers, 627 citations indexed

About

Marta Vachová is a scholar working on Pathology and Forensic Medicine, Neurology and Immunology. According to data from OpenAlex, Marta Vachová has authored 21 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 5 papers in Neurology and 5 papers in Immunology. Recurrent topics in Marta Vachová's work include Multiple Sclerosis Research Studies (9 papers), Cannabis and Cannabinoid Research (3 papers) and Peripheral Neuropathies and Disorders (2 papers). Marta Vachová is often cited by papers focused on Multiple Sclerosis Research Studies (9 papers), Cannabis and Cannabinoid Research (3 papers) and Peripheral Neuropathies and Disorders (2 papers). Marta Vachová collaborates with scholars based in Czechia, Slovakia and Poland. Marta Vachová's co-authors include Alena Novotná, Jan Mareš, S. Ratcliffe, Iveta Nováková, Richard Langford, William Notcutt, Olga Zapletalová, Claudio Gasperini, Xavier Montalbán and Paul Davies and has published in prestigious journals such as Journal of Neurology, Annals of Biomedical Engineering and European Journal of Neurology.

In The Last Decade

Marta Vachová

17 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marta Vachová Czechia 8 361 208 149 97 95 21 627
Iveta Nováková Czechia 7 493 1.4× 304 1.5× 257 1.7× 137 1.4× 123 1.3× 7 848
Zdeněk Ambler Czechia 5 347 1.0× 204 1.0× 172 1.2× 109 1.1× 88 0.9× 16 558
Jordan Trecki United States 15 475 1.3× 90 0.4× 99 0.7× 86 0.9× 254 2.7× 23 1.0k
Sarah Youssof United States 8 314 0.9× 47 0.2× 60 0.4× 8 0.1× 112 1.2× 14 560
Elena Kornyeyeva United States 5 261 0.7× 29 0.1× 25 0.2× 21 0.2× 67 0.7× 5 459
Valentina Castelli Italy 15 130 0.4× 27 0.1× 51 0.3× 12 0.1× 121 1.3× 40 589
Marisa Patrizia Messina Italy 16 54 0.1× 111 0.5× 26 0.2× 14 0.1× 114 1.2× 42 693
Joy A. Phillips United States 9 211 0.6× 25 0.1× 13 0.1× 154 1.6× 33 0.3× 27 458
Robert Marks United States 11 233 0.6× 190 0.9× 10 0.1× 16 0.2× 118 1.2× 15 655
Eromona Whiskey United Kingdom 18 95 0.3× 11 0.1× 96 0.6× 34 0.4× 29 0.3× 57 896

Countries citing papers authored by Marta Vachová

Since Specialization
Citations

This map shows the geographic impact of Marta Vachová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Vachová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Vachová more than expected).

Fields of papers citing papers by Marta Vachová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Vachová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Vachová. The network helps show where Marta Vachová may publish in the future.

Co-authorship network of co-authors of Marta Vachová

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Vachová. A scholar is included among the top collaborators of Marta Vachová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Vachová. Marta Vachová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Vaněčková, Manuela, Miloš Keřkovský, Pavel Ryška, et al.. (2024). Standardization of MRI in Multiple Sclerosis Management Consensus by the Czech Expert Radiology-Neurology Panel. Česká a slovenská neurologie a neurochirurgie. 87/120(1).
3.
Vališ, Martin, Michal Novotný, Blanka Klímová, et al.. (2022). Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry. Frontiers in Neurology. 13. 851426–851426. 3 indexed citations
4.
Hradílek, Pavel, Eva Meluzínová, Olga Zapletalová, et al.. (2021). Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech Republic. Multiple Sclerosis and Related Disorders. 59. 103391–103391. 4 indexed citations
5.
Ampapa, Radek, et al.. (2021). Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia. Multiple Sclerosis and Related Disorders. 54. 103104–103104. 22 indexed citations
6.
Sobíšek, Lukáš, Ivana Štětkářová, Pavel Štourač, et al.. (2021). Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS. Frontiers in Neurology. 11. 593527–593527. 3 indexed citations
7.
Horáková, Dana, Marta Vachová, Jan Mareš, et al.. (2021). Oral cladribine in the treatment of multiple sclerosis – data from the national registry ReMuS® registry. Česká a slovenská neurologie a neurochirurgie. 84/117(6). 1 indexed citations
8.
Horáková, Dana, Tomáš Doležal, Marta Vachová, et al.. (2019). Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS. Multiple Sclerosis and Related Disorders. 35. 196–202. 5 indexed citations
9.
Vaněčková, Manuela, Jiří Fiedler, Ivana Štětkářová, et al.. (2019). "The spectrum of MRI findings of progressive multifocal leukoencephalopathy in patients with multiple sclerosis in the Czech Republic". Česká a slovenská neurologie a neurochirurgie. 82/115(4). 381–390.
10.
Berger, Thomas, Monika Adamczyk‐Sowa, Tünde Csépány, et al.. (2018). Management of multiple sclerosis patients in central European countries: current needs and potential solutions. Therapeutic Advances in Neurological Disorders. 11. 1276980757–1276980757. 17 indexed citations
11.
12.
Preiningerová, Jana Lízrová & Marta Vachová. (2016). Daclizumab high-yield process in the treatment of relapsing–remitting multiple sclerosis. Therapeutic Advances in Neurological Disorders. 10(1). 67–75. 7 indexed citations
13.
14.
15.
Novotná, Alena, Jan Mareš, S. Ratcliffe, et al.. (2011). A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. European Journal of Neurology. 18(9). 1122–1131. 313 indexed citations
16.
Vachová, Marta, et al.. (2008). Symptomatická léčba roztroušené sklerózy. Neurologie pro praxi. 9(4). 226–231. 1 indexed citations
17.
Vachová, Marta. (1991). Biological approaches to the controlled delivery of drugs. Annals of Biomedical Engineering. 19(2). 233–235. 7 indexed citations
18.
Vachová, Marta, et al.. (1990). Effects of drug administration in pregnancy on children's school behaviour. Pharmacy World & Science. 12(6). 252–255. 30 indexed citations
19.
Drobník, J., et al.. (1979). The effect of polyaspartamides on drug‐metabolizing enzymes. Journal of Polymer Science Polymer Symposia. 66(1). 75–81. 10 indexed citations
20.
Vachová, Marta, et al.. (1978). Some cytostatic and pharmacological properties of 2,3-dihydro-1,3-6H-oxazine-2,6-dione ("3-oxauracil").. PubMed. 25(4). 413–21. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Iveta Nováková Breakdown of academic impact, for papers by Zdeněk Ambler Breakdown of academic impact, for papers by Jordan Trecki Breakdown of academic impact, for papers by Sarah Youssof Breakdown of academic impact, for papers by Elena Kornyeyeva Breakdown of academic impact, for papers by Valentina Castelli Breakdown of academic impact, for papers by Marisa Patrizia Messina Breakdown of academic impact, for papers by Joy A. Phillips Breakdown of academic impact, for papers by Robert Marks Breakdown of academic impact, for papers by Eromona Whiskey
Rankless by CCL
2026